Company Filing History:
Years Active: 2008-2015
Title: Frank Bordusa: Innovator in Peptide Synthesis
Introduction
Frank Bordusa is a notable inventor based in Rossbach, Germany. He has made significant contributions to the field of biochemistry, particularly in the synthesis of peptides and proteins. With a total of 2 patents, Bordusa's work has advanced the understanding and application of enzymatic processes in peptide modification.
Latest Patents
Bordusa's latest patents include a method for C-terminal modification of polypeptides. This invention involves a mutated trypsin that features specific amino acid substitutions, allowing for enhanced cleavage at designated sites. The trypsin mutant is designed to facilitate the production of C-terminally modified target peptides, showcasing its potential in biotechnological applications. Another significant patent focuses on a method for synthesizing peptides, peptide mimetics, and proteins. This method utilizes an enzyme as a biocatalyst, with modifications to enhance its specificity, thereby improving the efficiency of peptide synthesis.
Career Highlights
Throughout his career, Frank Bordusa has worked with prominent companies in the biotechnology sector, including Eucodis Bioscience GmbH and Roche Diagnostics GmbH. His experience in these organizations has contributed to his expertise in peptide synthesis and enzymatic processes.
Collaborations
Bordusa has collaborated with esteemed colleagues such as Hans-Dieter Jakubke and Eva Hoess. These partnerships have further enriched his research and development efforts in the field of biochemistry.
Conclusion
Frank Bordusa's innovative work in peptide synthesis and enzymatic processes has made a lasting impact on the field of biochemistry. His patents reflect a commitment to advancing scientific knowledge and practical applications in biotechnology.